Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:55 PM
Ignite Modification Date:
2025-12-24 @ 4:55 PM
NCT ID:
NCT01295450
Eligibility Criteria:
Inclusion Criteria:
* Patients who presents lack of appetite;
* Wash out 20 days after ingestion before similar drug;
* Responsible for the least able to understand and maintain their adherence to protocol;
* Patients of all ethnic groups of both sexes, aged 7-14 years;
* Responsible for the minor must consent to participate in the same study, through the signing of consentiment term;
* Responsible for the minor should be able to understand the proper use of medication;
Exclusion Criteria:
* Patients with parasitic infections;
* Patients with angle closure glaucoma or open;
* Patients with a predisposition to urinary retention;
* Patients with peptic ulcer or stenotic pylorus-duodenal obstruction;
* debilitated patients or in acute asthma attack;
* Patients who have poor appetite caused by any serious illness;
* Patients who are taking any medications that depress the central nervous system;
* Patients who take medication monoamine oxidase inhibitors, tricyclic antidepressants, phenothiazine, probenecid, levodopa, phenytoin, phenobarbital, chloramphenicol, cyclophosphamide, cyclosporine, chlorambucil, corticotrophin, mercaptopurine, isoniazid, penicillin, estrogens, contraceptives, haloperidol, ipatrópico, barbiturates, Primidone, salicylates;
* Patients with known hypersensitivity to any components of the formula;
* Patients who are participating in another clinical trial;
* Inability to compliance with the protocol;
* Any condition that in the opinion of the investigator would prohibit the inclusion and patient compliance with the protocol.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
7 Years
Maximum Age:
14 Years
Study:
NCT01295450
Study Brief:
Protocol Section:
NCT01295450